SOX2 and central nervous system cancer: Intriguingly, in adult astrocytic tumours, we previously noticed that the frequency of Sox2/CD44v9-negative and phospho-S6-positive tumour cell populations (differentiated tumour cells), but not Sox2/CD44v9-positive and phospho-S6-negative CSC populations, correlated with the grade of glioma.